Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Buy
52
OVBC Quote, Financials, Valuation and Earnings
Last price:
$30.09
Seasonality move
:
4.46%
Day range:
$29.02 - $31.60
52-week range:
$19.35 - $32.81
Dividend yield:
2.99%
P/E ratio:
12.71x
P/S ratio:
2.25x
P/B ratio:
0.92x
Volume:
36.6K
Avg. volume:
15.7K
1-year change:
22.83%
Market cap:
$138.9M
Revenue:
$62M
EPS (TTM):
$2.32
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $49.4M | $50.9M | $54.9M | $58.7M | $62M | |
| Revenue Growth (YoY) | -3.03% | 2.95% | 7.99% | 6.76% | 5.66% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $26M | $24.7M | $23.4M | $25M | $29.3M | |
| Other Inc / (Exp) | -- | -$1.1M | -$1.5M | -- | -- | |
| Operating Expenses | $28.1M | $24.7M | $23.4M | $25M | $29.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $12.3M | $14M | $15.9M | $15.2M | $13.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2M | $2.3M | $2.6M | $2.6M | $2.4M | |
| Net Income to Company | $10.3M | $11.7M | $13.3M | $12.6M | $11M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $10.3M | $11.7M | $13.3M | $12.6M | $11M | |
| Basic EPS (Cont. Ops) | $2.14 | $2.45 | $2.80 | $2.65 | $2.32 | |
| Diluted EPS (Cont. Ops) | $2.14 | $2.45 | $2.80 | $2.65 | $2.32 | |
| Weighted Average Basic Share | $4.8M | $4.8M | $4.8M | $4.8M | $4.7M | |
| Weighted Average Diluted Share | $4.8M | $4.8M | $4.8M | $4.8M | $4.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $18.5M | $17.7M | $18.8M | $31M | $40.3M | |
| Revenue (Reported) | $49.4M | $50.9M | $54.9M | $58.7M | $62M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $18.5M | $17.7M | $18.8M | $31M | $40.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.4M | $11.8M | $13.6M | $14.9M | $17M | |
| Revenue Growth (YoY) | 0.6% | -4.96% | 15.11% | 9.68% | 14.06% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.3M | $4.5M | $5.3M | $6.2M | $9.2M | |
| Other Inc / (Exp) | -- | -$1.1M | -$1.5M | -- | -- | |
| Operating Expenses | $5.3M | $4.5M | $5.3M | $6.2M | $9.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $5.8M | $2.8M | $4M | $3.9M | $3.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1M | $468K | $516K | $682K | $552K | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $4.7M | $2.3M | $3.5M | $3.2M | $2.5M | |
| Basic EPS (Cont. Ops) | $0.98 | $0.48 | $0.74 | $0.68 | $0.53 | |
| Diluted EPS (Cont. Ops) | $0.98 | $0.48 | $0.74 | $0.68 | $0.53 | |
| Weighted Average Basic Share | $4.8M | $4.8M | $4.8M | $4.8M | $4.7M | |
| Weighted Average Diluted Share | $4.8M | $4.8M | $4.8M | $4.8M | $4.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $7.1M | $3.5M | $4.9M | $9.7M | $10M | |
| Revenue (Reported) | $12.4M | $11.8M | $13.6M | $14.9M | $17M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $7.1M | $3.5M | $4.9M | $9.7M | $10M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $49.4M | $50.9M | $54.9M | $58.7M | $62M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $26M | $24.7M | $23.4M | $25M | $29.3M | |
| Other Inc / (Exp) | -- | -$1.1M | -$1.5M | -- | -- | |
| Operating Expenses | $28.1M | $24.7M | $23.4M | $25M | $29.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $12.3M | $14M | $15.9M | $15.2M | $13.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2M | $2.3M | $2.6M | $2.6M | $2.4M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $10.3M | $11.7M | $13.3M | $12.6M | $11M | |
| Basic EPS (Cont. Ops) | $2.14 | $2.45 | $2.80 | $2.65 | $2.32 | |
| Diluted EPS (Cont. Ops) | $2.14 | $2.45 | $2.80 | $2.65 | $2.32 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $18.5M | $17.7M | $18.8M | $31M | $40.3M | |
| Revenue (Reported) | $49.4M | $50.9M | $54.9M | $58.7M | $62M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $18.5M | $17.7M | $18.8M | $31M | $40.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $50.9M | $54.9M | $58.7M | $62M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $24.7M | $23.4M | $25M | $29.3M | -- | |
| Other Inc / (Exp) | -$1.1M | -$1.5M | -- | -- | -- | |
| Operating Expenses | $24.7M | $23.4M | $25M | $29.3M | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $14M | $15.9M | $15.2M | $13.4M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.3M | $2.6M | $2.6M | $2.4M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $11.7M | $13.3M | $12.6M | $11M | -- | |
| Basic EPS (Cont. Ops) | $2.45 | $2.80 | $2.65 | $2.32 | -- | |
| Diluted EPS (Cont. Ops) | $2.45 | $2.80 | $2.65 | $2.32 | -- | |
| Weighted Average Basic Share | $19.1M | $19.1M | $19.1M | $18.9M | -- | |
| Weighted Average Diluted Share | $19.1M | $19.1M | $19.1M | $18.9M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $17.7M | $18.8M | $31M | $40.3M | -- | |
| Revenue (Reported) | $50.9M | $54.9M | $58.7M | $62M | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $17.7M | $18.8M | $31M | $40.3M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $140.8M | $154.4M | $47.9M | $128.1M | $83.1M | |
| Short Term Investments | $112.3M | $177M | $184.1M | $162.3M | $198.6M | |
| Accounts Receivable, Net | $3.3M | $2.7M | $3.1M | $3.6M | $4.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $256.4M | $334.1M | $235M | $294M | $286.5M | |
| Property Plant And Equipment | $22.2M | $21.9M | $21.7M | $22.7M | $22.3M | |
| Long-Term Investments | $122.3M | $187.3M | $193.3M | $170.2M | $275.2M | |
| Goodwill | $7.3M | $7.3M | $7.3M | $7.3M | $7.3M | |
| Other Intangibles | $112K | $64K | $29K | $8K | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.2B | $1.2B | $1.2B | $1.4B | $1.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $36.4M | $28.1M | $26.4M | $53.1M | $48.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.1B | $1.1B | $1.1B | $1.2B | $1.4B | |
| Common Stock | $5.4M | $5.4M | $5.5M | $5.5M | $5.5M | |
| Other Common Equity Adj | -- | $708K | -$14.8M | -$11.4M | -$10.5M | |
| Common Equity | $136.3M | $141.4M | $135M | $144M | $150.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $136.3M | $141.4M | $135M | $144M | $150.3M | |
| Total Liabilities and Equity | $1.2B | $1.2B | $1.2B | $1.4B | $1.5B | |
| Cash and Short Terms | $253.1M | $331.4M | $231.9M | $290.4M | $281.7M | |
| Total Debt | $36.4M | $28.1M | $26.4M | $53.1M | $48.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $140.8M | $154.4M | $47.9M | $128.1M | $83.1M | |
| Short Term Investments | $112.3M | $177M | $184.1M | $162.3M | $198.6M | |
| Accounts Receivable, Net | $3.3M | $2.7M | $3.1M | $3.6M | $4.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $256.4M | $334.1M | $235M | $294M | $286.5M | |
| Property Plant And Equipment | $22.2M | $21.9M | $21.7M | $22.7M | $22.3M | |
| Long-Term Investments | $122.3M | $187.3M | $193.3M | $170.2M | $275.2M | |
| Goodwill | $7.3M | $7.3M | $7.3M | $7.3M | $7.3M | |
| Other Intangibles | $112K | $64K | $29K | $8K | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.2B | $1.2B | $1.2B | $1.4B | $1.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $36.4M | $28.1M | $26.4M | $53.1M | $48.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.1B | $1.1B | $1.1B | $1.2B | $1.4B | |
| Common Stock | $5.4M | $5.4M | $5.5M | $5.5M | $5.5M | |
| Other Common Equity Adj | -- | $708K | -$14.8M | -$11.4M | -$10.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $136.3M | $141.4M | $135M | $144M | $150.3M | |
| Total Liabilities and Equity | $1.2B | $1.2B | $1.2B | $1.4B | $1.5B | |
| Cash and Short Terms | $253.1M | $331.4M | $231.9M | $290.4M | $281.7M | |
| Total Debt | $36.4M | $28.1M | $26.4M | $53.1M | $48.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $10.3M | $11.7M | $13.3M | $12.6M | $11M | |
| Depreciation & Amoritzation | $1.5M | $1.6M | $1.6M | $1.6M | $1.7M | |
| Stock-Based Compensation | -- | -- | $575K | $125K | $500K | |
| Change in Accounts Receivable | -$755K | $624K | -$417K | -$494K | -$1.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $12.5M | $13.2M | $16M | $20.7M | $13.1M | |
| Capital Expenditures | $3.5M | $1.1M | $2M | $2.7M | $1.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$88.7M | -$52.4M | -$83.4M | -$59.8M | -$195.2M | |
| Dividends Paid (Ex Special Dividend) | -$4M | -$4M | -$4.7M | -$4.9M | -$4.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $600K | $2K | $30M | $2K | |
| Long-Term Debt Repaid | -$5.5M | -$7.8M | -$1.9M | -$3.4M | -$5M | |
| Repurchase of Common Stock | -- | -$954K | -- | -$82K | -$1.9M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $162.1M | $52.9M | -$38.6M | $121.2M | $137.1M | |
| Beginning Cash (CF) | $52.4M | $138.3M | $152M | $46M | $128.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $85.9M | $13.7M | -$106M | $82.1M | -$45M | |
| Ending Cash (CF) | $138.3M | $152M | $46M | $128.1M | $83.1M | |
| Levered Free Cash Flow | $9M | $12.1M | $14M | $18.1M | $11.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5M | $5.1M | $5.8M | $6.6M | $2.4M | |
| Capital Expenditures | $349K | $288K | $326K | $705K | $233K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $3.5M | $8.8M | -$25.1M | $949K | -$13M | |
| Dividends Paid (Ex Special Dividend) | -$1M | -$1M | -$1M | -$1.1M | -$1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $2K | $1K | $2K | |
| Long-Term Debt Repaid | -$1.1M | -$3.7M | -$381K | -$1.2M | -$1.2M | |
| Repurchase of Common Stock | -- | -$496K | -- | -- | -$14K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $46.3M | $3.1M | -$47.8M | $29.4M | $11.6M | |
| Beginning Cash (CF) | $83.6M | $135.1M | $113.1M | $91.2M | $82.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $54.7M | $17M | -$67.1M | $36.9M | $903K | |
| Ending Cash (CF) | $138.3M | $152M | $46M | $128.1M | $83.1M | |
| Levered Free Cash Flow | $4.6M | $4.8M | $5.4M | $5.9M | $2.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $12.5M | $13.2M | $16M | $20.7M | $13.1M | |
| Capital Expenditures | $3.5M | $1.1M | $2M | $2.7M | $1.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$88.7M | -$52.4M | -$83.4M | -$59.8M | -$195.2M | |
| Dividends Paid (Ex Special Dividend) | -$4M | -$4M | -$4.7M | -$4.9M | -$4.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$5.5M | -$7.8M | -$1.9M | -$3.4M | -$5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $162.1M | $52.9M | -$38.6M | $121.2M | $137.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $85.9M | $13.7M | -$106M | $82.1M | -$45M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $9M | $12.1M | $14M | $18.1M | $11.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.2M | $16M | $20.7M | $13.1M | -- | |
| Capital Expenditures | $1.1M | $2M | $2.7M | $1.4M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$52.4M | -$83.4M | -$59.8M | -$195.2M | -- | |
| Dividends Paid (Ex Special Dividend) | -$4M | -$4.7M | -$4.9M | -$4.2M | -- | |
| Special Dividend Paid | -- | $150K | $150K | -- | -- | |
| Long-Term Debt Issued | $600K | $2K | $30M | $2K | -- | |
| Long-Term Debt Repaid | -$7.8M | -$1.9M | -$3.4M | -$5M | -- | |
| Repurchase of Common Stock | -$954K | -- | -$82K | -$1.9M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $52.9M | -$38.6M | $121.2M | $137.1M | -- | |
| Beginning Cash (CF) | $575M | $523M | $283.8M | $447.1M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $13.7M | -$106M | $82.1M | -$45M | -- | |
| Ending Cash (CF) | $588.8M | $416.9M | $366M | $402.1M | -- | |
| Levered Free Cash Flow | $12.1M | $14M | $18.1M | $11.7M | -- | |
Get OVBC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OVBC
Sector
P/E ratio
12.71x
11.41x
PEG ratio
--
0.38x
P/B ratio
0.92x
1.07x
Price / LTM sales
2.25x
2.51x
Growth Metrics
OVBC
Sector
Revenue growth
14.06%
6.9%
Earnings growth
-22.06%
6.98%
Revenue (5-year growth)
3.99%
5.22%
Earnings forecast
--
$0.56
Profitability
OVBC
Sector
Profitability FY 2024
--
$161.4M
Return on invested capital
5.55%
5.53%
Return on assets
0.77%
0.99%
Return on equity
7.45%
9.5%
Earnings Date
Last Earnings Date
Jan
28
Next Earnings Date
Apr
25
Estimated Next Earnings Date
Apr
29
Balance Sheet
OVBC
Sector
Total cash
$281.7M
$485.1M
Short term investments
$198.6M
$263.9M
Total assets
$1.5B
$4.5B
Long term debt
$48.2M
$327.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
